HYPERLIPIDEMIAS
Clinical trials for HYPERLIPIDEMIAS explained in plain language.
Never miss a new study
Get alerted when new HYPERLIPIDEMIAS trials appear
Sign up with your email to follow new studies for HYPERLIPIDEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Herbal combo shows promise for high cholesterol
Disease control CompletedThis study looked at whether two natural herbs, Ashwagandha and Jamun, can help people with high cholesterol. Sixty adults with unhealthy cholesterol levels took one or both herbs for three months. Results suggest the combination may improve cholesterol numbers, but more research…
Matched conditions: HYPERLIPIDEMIAS
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New combo pill tackles blood pressure and cholesterol at once
Disease control CompletedThis study tested whether taking two drugs (DWC202206 and DWC202207) together is safe and effective for people with both high blood pressure and high cholesterol. 214 adults aged 19 to 80 took part. The goal was to see if the combination lowered blood pressure and LDL ("bad") cho…
Matched conditions: HYPERLIPIDEMIAS
Phase: PHASE3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for kidney transplant patients: cholesterol drug evolocumab shows promise
Disease control CompletedThis study tested the drug evolocumab (Repatha) in 81 kidney transplant recipients with high cholesterol. The goal was to see if it could safely lower cholesterol levels, since standard statin drugs often cause side effects in these patients. The results could lead to a better wa…
Matched conditions: HYPERLIPIDEMIAS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New shot shows promise in lowering 'Bad' cholesterol in large trial
Disease control CompletedThis Phase 3 study tested a new injectable drug called SAL003 in 618 adults with high cholesterol or mixed dyslipidemia. Participants received either SAL003 or a placebo every 4 weeks for 12 weeks, then all received SAL003 for another 40 weeks. The main goal was to see if SAL003 …
Matched conditions: HYPERLIPIDEMIAS
Phase: PHASE3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New program aims to cut heart risk in rheumatoid arthritis patients
Disease control CompletedThis study tested a program to help people with rheumatoid arthritis (RA) get their cholesterol checked and treated. Many RA patients are at higher risk for heart attacks and strokes but often miss out on proper screening. The program used peer coaches and educational materials t…
Matched conditions: HYPERLIPIDEMIAS
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can asking patients about their needs reduce hospital visits?
Knowledge-focused CompletedThis study looked at two ways to assign care coordinators to older adults (65+) with heart disease or risk factors. One method used patients' own reports of difficulty coordinating care, while the other used usual triggers like hospital discharge. The goal was to see which approa…
Matched conditions: HYPERLIPIDEMIAS
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:18 UTC